CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |